Guarantor Information (Consolidating Statement of Income) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 27, 2014	Sep. 27, 2014	Jun. 28, 2014	Mar. 29, 2014	Dec. 28, 2013	Sep. 28, 2013	Jun. 29, 2013	Mar. 30, 2013	Dec. 27, 2014		Dec. 28, 2013		Dec. 29, 2012
Condensed Financial Statements, Captions [Line Items]
Net sales	$ 679.9	$ 588.7	$ 674.3	$ 663.2	$ 717.1	$ 603.2	$ 688.4	$ 662.9	$ 2,606.1		$ 2,671.6		$ 2,583.8
Other revenue									0		0		0
Cost of products sold									884.0		889.8		856.4
Gross margin	452.4	379.5	448.6	441.6	475.7	403.6	462.4	440.1	1,722.1		1,781.8		1,727.4
Delivery, sales and administrative expense									1,346.1		1,369.7		1,329.5
Re-engineering and impairment charges	2.7	2.6	3.4	2.3	2.2	2.7	2.2	2.2	11.0	[1]	9.3	[1]	22.4	[1]
Impairment of goodwill and intangible assets									0	[2]	0	[2]	76.9	[2]
Gains on disposal of assets including insurance recoveries, net									2.7		0.7		7.9
Operating income									367.7		403.5		306.5
Interest income									3.0		2.6		2.5
Interest expense									46.5		40.2		34.9
Income from equity investments in subsidiaries									0		0		0
Other (income) expense									26.0		5.5		1.3
Income before income taxes									298.2		360.4		272.8
Provision for income taxes									83.8		86.2		79.8
Net income	82.3	32.3	47.6	52.2	89.8	49.9	76.3	58.2	214.4		274.2		193.0
Total comprehensive income									122.5		228.7		217.2
Reportable Legal Entities [Member] | Parent [Member]
Condensed Financial Statements, Captions [Line Items]
Net sales									0		0		0
Other revenue									0		0		0
Cost of products sold									0		0		0
Gross margin									0		0		0
Delivery, sales and administrative expense									19.5		20.8		21.7
Re-engineering and impairment charges									0		0		0
Impairment of goodwill and intangible assets													0
Gains on disposal of assets including insurance recoveries, net									0		0		0
Operating income									(19.5)		(20.8)		(21.7)
Interest income									0.4		0.4		1.6
Interest expense									36.3		33.8		28.1
Income from equity investments in subsidiaries									250.3		308.9		223.8
Other (income) expense									0		0		0
Income before income taxes									194.9		254.7		175.6
Provision for income taxes									(19.5)		(19.5)		(17.4)
Net income									214.4		274.2		193.0
Total comprehensive income									122.5		228.7		217.2
Reportable Legal Entities [Member] | Guarantor [Member]
Condensed Financial Statements, Captions [Line Items]
Net sales									0		0		0
Other revenue									138.5		124.6		128.2
Cost of products sold									25.9		18.3		30.9
Gross margin									112.6		106.3		97.3
Delivery, sales and administrative expense									67.1		72.0		55.4
Re-engineering and impairment charges									0.1		0		0
Impairment of goodwill and intangible assets													0
Gains on disposal of assets including insurance recoveries, net									0		0		0.5
Operating income									45.4		34.3		42.4
Interest income									28.9		30.9		30.9
Interest expense									20.7		19.8		20.4
Income from equity investments in subsidiaries									217.4		280.9		180.8
Other (income) expense									0.2		(0.1)		1.0
Income before income taxes									270.8		326.4		232.7
Provision for income taxes									20.8		18.7		11.2
Net income									250.0		307.7		221.5
Total comprehensive income									160.9		262.7		248.8
Reportable Legal Entities [Member] | Non-Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Net sales									2,613.9		2,679.0		2,591.3
Other revenue									25.9		18.3		30.8
Cost of products sold									1,020.8		1,012.3		992.0
Gross margin									1,619.0		1,685.0		1,630.1
Delivery, sales and administrative expense									1,269.0		1,286.4		1,252.4
Re-engineering and impairment charges									10.9		9.3		22.4
Impairment of goodwill and intangible assets													76.9
Gains on disposal of assets including insurance recoveries, net									2.7		0.7		7.4
Operating income									341.8		390.0		285.8
Interest income									4.4		7.4		4.9
Interest expense									20.2		22.7		21.3
Income from equity investments in subsidiaries									0		0		0
Other (income) expense									25.8		5.6		0.3
Income before income taxes									300.2		369.1		269.1
Provision for income taxes									82.5		87.0		86.0
Net income									217.7		282.1		183.1
Total comprehensive income									166.4		249.4		178.6
Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Net sales									(7.8)		(7.4)		(7.5)
Other revenue									(164.4)		(142.9)		(159.0)
Cost of products sold									(162.7)		(140.8)		(166.5)
Gross margin									(9.5)		(9.5)		0
Delivery, sales and administrative expense									(9.5)		(9.5)		0
Re-engineering and impairment charges									0		0		0
Impairment of goodwill and intangible assets													0
Gains on disposal of assets including insurance recoveries, net									0		0		0
Operating income									0		0		0
Interest income									(30.7)		(36.1)		(34.9)
Interest expense									(30.7)		(36.1)		(34.9)
Income from equity investments in subsidiaries									(467.7)		(589.8)		(404.6)
Other (income) expense									0		0		0
Income before income taxes									(467.7)		(589.8)		(404.6)
Provision for income taxes									0		0		0
Net income									(467.7)		(589.8)		(404.6)
Total comprehensive income									$ (327.3)		$ (512.1)		$ (427.4)

[1] The re-engineering and impairment charges line includes severance expenses and other exit costs. See Note 2 to the Consolidated Financial Statements.

[2] Reviews of the value of the intangible assets related to the acquisition of the Sara Lee direct-to-consumer units acquired in 2005 and BeautiControl acquired in 2000, resulted in the conclusion that certain of the tradenames and goodwill had been impaired in 2012. This resulted in charges of $76.9 million related to BeautiControl, NaturCare and Nutrimetics. There were no such impairments in 2013 and 2014. See Note 6 for further details.